FIELD: biotechnology.
SUBSTANCE: disclosed are a culture medium containing from 10 ng/ml to 100 ng/ml of amphiregulin, epidermal growth factor, insulin, B27, ROCK kinase inhibitor Y27632, neuregulin 1, fibroblast growth factor 7, TGFβ receptor inhibitor type I A8301 and a P38/MAPK SB202190 inhibitor, but not containing Wnt agonists, for culturing primary epithelial cells of the mammary gland; method for culturing primary epithelial cells of the mammary gland, involving the use of said medium; and a method for evaluating the efficacy of a drug for treating breast diseases, involving culturing mammary epithelial cells using the disclosed method and detecting their viability in the presence of the drug.
EFFECT: inventions provide reduced duration of cultivation, increased proliferation and homogeneity of primary epithelial cells of mammary gland, which can be used for evaluation of drugs in treatment of diseases of mammary gland.
8 cl, 9 dwg, 3 tbl, 8 ex
Title | Year | Author | Number |
---|---|---|---|
CULTURE MEDIUM FOR EPITHELIAL CELLS OF ESOPHAGEAL SQUAMOUS CELL CARCINOMA, METHOD OF CULTIVATION AND USE THEREOF | 2020 |
|
RU2816529C1 |
CULTURE MEDIUM FOR EPITHELIAL CELLS OF LARYNGEAL CANCER, METHOD OF CULTIVATION AND USE THEREOF | 2020 |
|
RU2814719C1 |
CULTURE MEDIUM FOR STEM CELLS | 2012 |
|
RU2714256C2 |
CULTURE MEDIUM FOR EPITHELIAL STEM CELLS AND ORGANOIDS, CONTAINING THEREOF | 2010 |
|
RU2555545C2 |
CULTURE MEDIUM FOR PRIMARY CELLS OF OESOPHAGEAL SQUAMOUS CELL CARCINOMA AND METHOD OF CULTURING SAID CELLS | 2020 |
|
RU2822035C1 |
PREPARATION INHIBITING MALIGNANT TUMOUR DEVELOPMENT AND CONTAINING DIS-A-FIBRIN | 2005 |
|
RU2358754C2 |
METHOD FOR PRODUCING TISSUE-ENGINEERED IN VITRO MODEL OF HUMAN HEAD AND NECK SQUAMOUS CELL CARCINOMA | 2023 |
|
RU2825474C1 |
LIVER ORGANOID, VERSIONS OF USE THEREOF AND CULTURE METHOD FOR PRODUCTION THEREOF | 2011 |
|
RU2579995C2 |
METHOD FOR PRODUCING ORGANOIDS FROM TUMOUR TISSUE OF THE HEAD AND NECK | 2021 |
|
RU2787378C1 |
IMPROVED DIFFERENTIATION METHOD | 2017 |
|
RU2772435C2 |
Authors
Dates
2024-05-17—Published
2019-11-18—Filed